IGFBP3 and myocardial infarction: The experiments performed showed that ISL1-hMSC administration improved cardiac function, and ISL1 overexpression enhanced cardioprotection by promoting hMSC survival in MI and enhancing their paracrine function, which may be mediated through insulin-like growth factor binding protein 3 (IGFBP3).